90
Participants
Start Date
September 1, 2025
Primary Completion Date
September 15, 2025
Study Completion Date
September 30, 2026
Urtica dioica cataplasm
Participants will receive a warm Urtica dioica cataplasm applied topically on the affected knee, once daily for 60 minutes, three times per week (on alternate days) over a 6-week period.
Placebo
Participants will receive a placebo cataplasm, matched in texture, color, and odor to the active treatment. The placebo is inert and safe for pediatric topical use.
Vitamin D
Participants will receive oral vitamin D.
Resting conditions
Reduction in physical activity based on orthopedic advice.
Faculty of Medicine, Sousse
OTHER